undamentalytics Newsletter
Sign in

Cardio Diagnostics Holdings, Inc. revenue

Cardio Diagnostics Holdings, Inc.'s revenue was $14,825 in fiscal 2025, down 57.5% on the year before. Since fiscal 2021 ($901) it has grown at a compound 101.4% a year. Over the last twelve months it was $14,450.

Revenue history

US$ thousands unless shown otherwise. Fiscal years, plus the last twelve months (LTM) when newer.

Fiscal year2021Dec 20212022Dec 20222023Dec 20232024Dec 20242025Dec 2025LTMJun 2026
Revenue1117351514
Growth on the year before—+5.4%+>999%+104.5%−57.5%—

Revenue as reported in the company's 10-K and 10-Q filings (for banks, net interest income plus non-interest income). Growth is left blank when the earlier figure was zero or negative.

Revenue against peers

Health Care Equipment: the closest covered companies by revenue. Last twelve months.

CompanyRevenueGrowth3-year growth a year
Cardio Diagnostics Holdings, Inc. $14,450 -25.9% 75.5%
Cuprina Holdings (cayman) LTD $38,204 5.6% —
Heartsciences Inc. $4,519 -64.2% —
Phaos Technology Holdings (cayman) Ltd $102,806 -18.2% —
Pavmed Inc. $112,000 -89.0% -49.6%
Nexalin Technology, Inc. $217,155 24.2% -30.6%

Compare with peers

Head to head: CDIO vs CUPRCDIO vs HSCSCDIO vs POAS

More: Health Care Equipment stocks compared, Health Care sector, rankings of US companies

Figures from Cardio Diagnostics Holdings, Inc.'s SEC filings (10-K and 10-Q), retrieved October 29, 2026. How we read and check them: methodology and data sources. Not investment advice. Back to Cardio Diagnostics Holdings, Inc.